Doxorubicin-Induced Apoptosis in Murine Cancer Model: A Gene Expression Profiling Study

Authors

  • Sara Ahmed El-Said and Iman E. El-Araby Author

DOI:

https://doi.org/10.48047/0nencd54

Keywords:

Cancer, doxorubicin chemotherapy, PCR; apoptosis

Abstract

Background: Objectives: Doxorubicin (Dox) used in cancer treatment in female mice as an experimental animal. 
Methods:  Mice were treated intraperitoneally with 0.026 mg/ml of doxorubicin chemotherapy once every 7 days ucedfor 30 days. Simultaneously, mice received distilled water by oral gavage or were intraperitonially injected with a single dose of Ehrlich Ascites Carcinoma and kept as negative and positive controls, respectively. Real-time PCR technique were used to evaluate the apoptosis in the liver of treated mice.

Downloads

Download data is not yet available.

References

Chen, M., Yi, Y., Chen, B., Zhang, H., Dong, M., Yuan, L., ... and Ma, Z., 2024. Metformin inhibits OCTN1-and OCTN2-mediated hepatic accumulation of doxorubicin and alleviates its hepatotoxicity in mice. Toxicol. 503, 153757.

Gilliam, L. A., Lark, D. S., Reese, L. R., Torres, M. J., Ryan, T. E., Lin, C. T., ... & Neufer, P. D., 2016. Targeted overexpression of mitochondrial catalase protects against cancer chemotherapy-induced skeletal muscle dysfunction. American Journal of Physiology-Endocrinology and Metabolism, 311(2), E293-E301.

Downloads

Published

2024-11-30

How to Cite

Doxorubicin-Induced Apoptosis in Murine Cancer Model: A Gene Expression Profiling Study (Sara Ahmed El-Said and Iman E. El-Araby , Trans.). (2024). Cuestiones De Fisioterapia, 53(03), 5750-5754. https://doi.org/10.48047/0nencd54